Evaluation of non-conformities in the drafting of bulletins for urine cytobacteriological examinations at Sikasso Hospital (Mali).

IF 2 Q3 PHARMACOLOGY & PHARMACY

Drug Target Insights Pub Date : 2024-01-16 eCollection Date: 2024-01-01 DOI:10.33393/dti.2024.2670

Luka Diarra, Moussa Mariko, Salif Traore, Safi Bazi Dicko, Aboudou Dolo, Moussa Coulibaly, Daouda Sidibé, Moumouni Daou, Hachimi Poma, Madou Traore, Ibrahim Guindo

{"title":"Evaluation of non-conformities in the drafting of bulletins for urine cytobacteriological examinations at Sikasso Hospital (Mali).","authors":"Luka Diarra, Moussa Mariko, Salif Traore, Safi Bazi Dicko, Aboudou Dolo, Moussa Coulibaly, Daouda Sidibé, Moumouni Daou, Hachimi Poma, Madou Traore, Ibrahim Guindo","doi":"10.33393/dti.2024.2670","DOIUrl":null,"url":null,"abstract":"Background: Non-compliance in the drafting of examination bulletins makes it difficult to perform them and interpret the results. With the aim of continuously improving laboratory services and guaranteeing the quality of urine cytobacteriological examination (ECBU) results, we initiated this study to evaluate non-compliance in the drafting of ECBU reports.Materials and methods: This was a retrospective descriptive cross-sectional study which focused on non-compliance in the drafting of ECBU reports analysed in the laboratory from January to December 2022.Results: During the study period, we collected 383 non-compliant ECBU reports out of 672, with a frequency of 56.99%. Non-compliances were related to age (2.68%), profession (24.40%), clinical information (6.70%) and residence (52.08%). The majority of non-compliant reports came from the medicine (35.51%) and urology (25.85%) departments.Conclusion: The high frequency of non-compliance is a cause for concern and is of concern to all prescribers in this hospital.","PeriodicalId":11326,"journal":{"name":"Drug Target Insights","volume":"18 ","pages":"1-3"},"PeriodicalIF":2.0000,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792388/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Target Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33393/dti.2024.2670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Non-compliance in the drafting of examination bulletins makes it difficult to perform them and interpret the results. With the aim of continuously improving laboratory services and guaranteeing the quality of urine cytobacteriological examination (ECBU) results, we initiated this study to evaluate non-compliance in the drafting of ECBU reports.

Materials and methods: This was a retrospective descriptive cross-sectional study which focused on non-compliance in the drafting of ECBU reports analysed in the laboratory from January to December 2022.

Results: During the study period, we collected 383 non-compliant ECBU reports out of 672, with a frequency of 56.99%. Non-compliances were related to age (2.68%), profession (24.40%), clinical information (6.70%) and residence (52.08%). The majority of non-compliant reports came from the medicine (35.51%) and urology (25.85%) departments.

Conclusion: The high frequency of non-compliance is a cause for concern and is of concern to all prescribers in this hospital.

查看原文本刊更多论文

评估锡卡索医院（马里）尿液细胞细菌学检查公告起草过程中的不合规之处。

背景：由于检查公告的起草不合规，导致难以执行检查和解释结果。为了不断改进实验室服务并保证尿液细胞细菌学检查（ECBU）结果的质量，我们发起了这项研究，以评估在起草 ECBU 报告时的违规行为：这是一项回顾性描述性横断面研究，重点关注实验室在2022年1月至12月期间分析的尿液细胞细菌学检查（ECBU）报告撰写过程中的违规行为：在研究期间，我们收集了672份ECBU报告中的383份不合规报告，频率为56.99%。不符合要求的报告与年龄（2.68%）、职业（24.40%）、临床信息（6.70%）和居住地（52.08%）有关。大多数违规报告来自内科（35.51%）和泌尿科（25.85%）：结论：违规频率之高令人担忧，也值得该医院所有处方者关注。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Target Insights PHARMACOLOGY & PHARMACY-

CiteScore

2.70

自引率

0.00%

发文量

审稿时长

8 weeks